Back
ACADIA Pharmaceuticals 10K Form
Sell
34
ACAD
ACADIA Pharmaceuticals
Last Price:
23.58
Seasonality Move:
-0.28%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-06 | 10Q | ACAD/ACADIA Pharmaceuticals Quarterly |
| 2020-05-08 | 10Q | ACAD/ACADIA Pharmaceuticals Quarterly |
| 2020-02-27 | 10K | ACAD/ACADIA Pharmaceuticals Annual |
| 2019-10-31 | 10Q | ACAD/ACADIA Pharmaceuticals Quarterly |
| 2019-08-01 | 10Q | ACAD/ACADIA Pharmaceuticals Quarterly |
| 2019-05-02 | 10Q | ACAD/ACADIA Pharmaceuticals Quarterly |
Receive ACAD News And Ratings
See the #1 stock for the next 7 days that we like better than ACAD
ACAD Financial Statistics
Sales & Book Value
| Annual Sales: | $517.24M |
|---|---|
| Cash Flow: | $-31.8M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.42 |
| Price / Book: | 9.75 |
Profitability
| EPS (TTM): | -0.69000 |
|---|---|
| Net Income (TTM): | $-110.82M |
| Gross Margin: | $507.07M |
| Return on Equity: | -27.28% |
| Return on Assets: | -17.87% |
ACADIA Pharmaceuticals Earnings Forecast
Key ACADIA Pharmaceuticals Financial Ratios
- The Gross Profit Margin over the past 18 years for ACAD is 98.03%.
- The Selling, General & Administrative Expenses for ACAD have been equal to 71.36% of Gross Profit Margin.
- The Research & Development expenses have been 69.91% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of ACAD is -41.76% of Total Revenues.
- Per Share Earnings over the last 23 years have been positive in 10 years.
ACADIA Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Current Symbol: | ACAD |
| CUSIP: | 004225 |
| Website: | acadia-pharm.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 2.62 |
| Quick Ratio: | 2.45 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 36.96 |
ACAD Technical Analysis vs Fundamental Analysis
Sell
34
ACADIA Pharmaceuticals (ACAD)
is a Sell
Is ACADIA Pharmaceuticals a Buy or a Sell?
-
ACADIA Pharmaceuticals stock is rated a Sell
The current ACADIA Pharmaceuticals [ACAD] share price is $23.56. The Score for ACAD is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.